Cargando…

Overnight switch from levetiracetam to brivaracetam. Safety and tolerability

Brivaracetam is a newer antiseizure medication than levetiracetam. It has a more selective action on the synaptic vesicle glycoprotein 2A binding site, and it seems to provide a more favorable neuropsychiatric profile. The aim of this study was to assess the safety and tolerability of an overnight s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraira, L., Salas-Puig, J., Quintana, M., Seijo-Raposo, I.M., Santamarina, E., Fonseca, E., Toledo, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640256/ https://www.ncbi.nlm.nih.gov/pubmed/34901817 http://dx.doi.org/10.1016/j.ebr.2021.100504

Ejemplares similares

Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience
por: Steinhoff, Bernhard J., et al.
Publicado: (2019)

The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability
por: Hung, Te-Yu, et al.
Publicado: (2021)

Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals
por: Beaty, Silky, et al.
Publicado: (2021)

Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein
por: Fukuyama, Kouji, et al.
Publicado: (2022)

Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients
por: Reed, Ronald C., et al.
Publicado: (2020)

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open‐label trial
por: Farkas, Mark Kristof, et al.
Publicado: (2022)

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
por: Liu, Edwin, et al.
Publicado: (2019)

Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?
por: Swallow, Elyse, et al.
Publicado: (2017)

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
por: Villanueva, Vicente, et al.
Publicado: (2023)

A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers
por: Finnema, Sjoerd J., et al.
Publicado: (2019)

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

Drug characteristics derived from kinetic modeling: combined (11)C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A
por: Naganawa, Mika, et al.
Publicado: (2022)

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
por: Ben-Menachem, Elinor, et al.
Publicado: (2016)

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design
por: Bast, Thomas, et al.
Publicado: (2022)

Efficacy and Tolerability of Intravenous Levetiracetam in Children
por: Aceves, Jose, et al.
Publicado: (2013)

Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis
por: Song, Ting, et al.
Publicado: (2023)

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018)

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
por: Willems, Laurent M., et al.
Publicado: (2018)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

A review of the pharmacology and clinical efficacy of brivaracetam
por: Klein, Pavel, et al.
Publicado: (2018)

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa, Anteneh M
Publicado: (2019)

Perampanel: A therapeutic alternative in refractory status epilepticus associated with MELAS syndrome
por: Santamarina, Estevo, et al.
Publicado: (2019)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
por: Seystahl, Katharina, et al.
Publicado: (2022)

Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study
por: Maschio, Marta, et al.
Publicado: (2020)

Overnight Orthokeratology: Technology, Efficiency, Safety, and Myopia Control
por: Villa-Collar, César, et al.
Publicado: (2019)

Synthesis of the Brivaracetam Employing Asymmetric Photocatalysis and Continuous Flow Conditions
por: Franco, Marcelo S., et al.
Publicado: (2023)

Synthetic Approaches toward the Synthesis of Brivaracetam: An Antiepileptic Drug
por: Gayke, Manoj, et al.
Publicado: (2022)

Epileptic seizures in the emergency room: clinical and electroencephalographic findings associated with brain perfusion patterns on computed tomography
por: Restrepo-Vera, JL, et al.
Publicado: (2022)

Brivaracetam Induced Encephalopathy: Why Mend Something Which isn't Broken
por: Agarwal, Ayush, et al.
Publicado: (2022)

Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer’s disease mouse model
por: Nygaard, Haakon B, et al.
Publicado: (2015)

Emerging drugs for partial-onset epilepsy: a review of brivaracetam
por: Gao, Lan, et al.
Publicado: (2016)

Brivaracetam: a novel antiepileptic drug for focal-onset seizures
por: Stephen, Linda J., et al.
Publicado: (2017)

New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017)

In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells
por: Rizzo, Ambra, et al.
Publicado: (2017)

Time course of 75%–100% efficacy response of adjunctive brivaracetam
por: Klein, Pavel, et al.
Publicado: (2020)

Rise of the Machines? Predicting Brivaracetam Response Using Machine Learning
por: Terman, Samuel W.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qmvouvvljj0o6gp3eq8f3gi358